Remifentanil as pain relief during labour

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-004577-23-NO

Enrollment

120

Registered

2005-10-31

Start date

2005-12-29

Completion date

Unknown

Last updated

2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labour pain

Interventions

Trade Name: Ultiva Product Name: Remifentanil hydrochloride Pharmaceutical Form: Injection* Trade Name: Naropin Pharmaceutical Form: Injection* Trade Name: Fentanyl Product Name: Fentanyl Pharmaceut

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy primiparaous woman with a normal pregnancy coming to full term labour, wishing pain relief to stand the labour pain. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Abnormal pregnancy or labour (Hypertension, bleeding disturbances, pregnancy intoxication, multiple foetous, abnormal foetus) Any other opioid given within the 8 last hours before study start

Design outcomes

Primary

Measure	Time frame
Main Objective: Evaluating the efficacy and safety of a short acting opioid (Remifentanil) given as intravenous PCA boluses for labour pain;Secondary Objective: Compare intravenous PCA Remifentanil treatment with standard epidural analgesia for labour pain concerning efficacy, patient and midwife preferances;Primary end point(s): To induce satisfying pain relief to help the mother to fulfill a spontanous labour	—

Measure

Time frame

Main Objective: Evaluating the efficacy and safety of a short acting opioid (Remifentanil) given as intravenous PCA boluses for labour pain;Secondary Objective: Compare intravenous PCA Remifentanil treatment with standard epidural analgesia for labour pain concerning efficacy, patient and midwife preferances;Primary end point(s): To induce satisfying pain relief to help the mother to fulfill a spontanous labour

—

Countries

Norway

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026